Bank7 (BSVN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BSVN, SBFG, and SVM made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 31, 2024.
BSVN, OKTA and SVM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 25, 2024.
BSVN, OKTA, SVM, SFIX and XAIR have been added to the Zacks Rank #1 (Strong Buy) List on July 25, 2024.
SAN, BSVN and SVM made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 25, 2024.
Bank7 (BSVN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Bank7 (BSVN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Bank7 Corporation (NASDAQ:BSVN ) Q2 2024 Earnings Conference Call July 11, 2024 11:00 AM ET Company Participants Thomas Travis - President and Chief Executive Officer Kelly Harris - Chief Financial Officer Jason Estes - Chief Credit Officer Conference Call Participants Woody Lay - KBW Nathan Race - Piper Sandler Jordan Ghent - Stephens Operator Good day and welcome to the Bank7 Corp. Second Quarter Earnings Call. Before we get started, I'd like to highlight the legal information and disclaimer on Page 26 of the investor presentation.
Bank7 (BSVN) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $1.05 per share a year ago.
Bank7 (BSVN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.